Previous close | 0.0710 |
Open | 0.0720 |
Bid | 0.0630 x 281200 |
Ask | 0.0690 x 14158300 |
Day's range | 0.0610 - 0.0720 |
52-week range | 0.0610 - 0.3758 |
Volume | |
Avg. volume | 283,411 |
Market cap | 19.055M |
Beta (5Y monthly) | 1.52 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0600 |
Earnings date | 29 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
CardieX ( ASX:CDX ) Full Year 2023 Results Key Financial Results Revenue: AU$5.95m (up 26% from FY 2022). Net loss...
ATCOR Medical, subsidiary of CardieX and developer of innovative medical devices and digital solutions to personalize healthcare and improve clinical trial patient outcomes, today announces it has entered into a partnership agreement with Datacubed Health, a leading eClinical technology company, advancing access to healthcare for everyone, everywhere.
Cardiovascular health technology company, CardieX Limited, is pleased to announce it has been selected as part of MedTech Innovator's 2023 Accelerator Cohort.